August 25, 2010
Bioniche & University of Ottawa Sign Exclusive Global License Agreement for Natural Health Technology

August 20, 2010
Additional Phase III Clinical Trial with UrocidinTM Expected to Commence in 2010

Check latest
stock price

All prices delayed at least 15 minutes.
Source: TSX Inc.

Hy Isenbaum, Former Chair, Board of Directors  

 
Mr. Hy Isenbaum was Chair of the Board of Directors of Bioniche Life Sciences Inc. from 1999 until 2008. He became Chair when Bioniche Life Sciences Inc. was formed through an amalgamation of Bioniche Inc., Renaissance Life Sciences Inc., and Vetrepharm Animal Health Inc.  

Mr. Isenbaum was a Fellow Chartered Accountant and the founder of the firm Soberman, Isenbaum and Colomby. As the Managing Partner, a position he held until 1993, he built his firm to be the 15th largest accounting practice in Canada. He was a Chairman of the Board and Chairman Emeritus of the Mount Sinai Hospital in Toronto. He was appointed by the Ontario Ministry of Health as Ombudsman to the Medical Review Committee of the College of Physicians and Surgeons. He served on the Board of Directors of the Samuel Lumenfeld Research Institute in Toronto and was instrumental in the establishment of the Institute. Mr. Isenbaum was also a Governor of the Weizman Institute of Science in Israel and sat on the Boards of a number of private and public companies.  

In his role with the Bioniche Board of Directors, Mr. Isenbaum contributed financial expertise and vigilance regarding the Company’s financial dealings. Additionally, he provided a high level, conservative, ethical tone that permeates the Company today in all departments, including accounting, marketing, regulatory affairs, and product development, as well as the overall conduct of the business.  

The Hy Isenbaum Award  
In honour of Mr. Isenbaum’s extensive contributions to Bioniche Life Sciences Inc., the “Hy Isenbaum Award” was created in 2008. It will be presented annually to the Bioniche employee who best epitomizes the Bioniche spirit. Employees who consistently exemplify the attributes of the company spirit, values, beliefs and image attributes – whether at work or in the community – are eligible for this award and may be nominated by his/her peers.  

2010 Recipient - Monique Champagne

Congratulations to the 2010 recipient of the Hy Isenbaum Award: Monique Champagne, Director of Clinical Research in our Bioniche Therapeutics group (Pointe-Claire - Frontenac). Monique has been with Bioniche since March, 2006. She brought with her nineteen years' experience in international research. She has held research and development management positions at Xanthus Life Sciences, Supratek Pharma Inc., PriceWaterhouseCoopers, Quintiles Canada, Wyeth-Ayerst Research and Scat Canada Inc. Her educational qualifications include a Masters in Pharmaceutical Science and a Bachelors degree in Pharmacy.

Her position requires a complete understanding of the research efforts of the Company. Monique is called upon to interact with all personnel in many departments, in particular, Regulatory, Legal, Marketing, Medical Information, Pharmacovigilance, Compassionate Use and Basic Science officers. She must be aware of the disease epidemiology, the patterns of treatment, the competitive drugs in development and the nature of the unmet medical needs for all sectors of research activity. In her role, she must develop strong relationships with the opinion leaders and M.D. consultants of Bioniche, and also act as an advisor and support to the Chief Medical Officer.

Here are some of Monique's attributes that helped her win this esteemed award:

"Monique is always respectful of everyone's opinion. People respect her and want to be on her team."

"Monique works with daily, weekly, monthly and yearly objectives... every day, she has work to be completed and does not rest or leave the workplace before it is accomplished."

"I find Monique to be one of the most committed employees of Bioniche. Through hard times and through changing times, she always continued to believe in Bioniche."

"Monique has a very high level of expertise in clinical research. Our Clinical Research Associates look upon her as an authority in her domain."

"Monique has accomplished a lot since joining our ranks, helping to redefine the clinical research sector and bringing it to a level of quality that has been instrumental in obtaining a deal with Endo Pharmaceuticals."

Congratulations, Monique, on this well-deserved recognition from your colleagues.

2009 Recipient

2008 Recipient